GGrantIndex
← Leaderboards

Charles S Dela Cruz

Va Connecticut Healthcare System

$3,480,030
Attributed
$5,081,937
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY201025
$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,022,558 · 7
VA$0 · 1

By mechanism

R01$3,338,054 · 2
U19$940,621 · 1
K08$669,600 · 1
R38$578,658 · 1
R21$460,625 · 1
R13$35,000 · 1

Others in their field

Top investigators on “Lung

Research focus

LungPathway InteractionsInflammatoryResponseVirus DiseasesInflammationReportingStainsPathologySignal TransductionInfectionMorbidity - Disease RateInsightGrantInterferon Type IProductionInterferonsAdultPneumoniaMacrophageMediatingMouse ModelPathogenesisRegulation

Grant awards (23)

Pittsburgh Innovation in Collaborative Training of Residents Alliance$289,329
R38 · FY2025 · HL · contact PI
2025 Pittsburgh Lung Conference: The Science of Medicine: Developing the Next Generation of Physician Scientists$35,000
R13 · FY2025 · HL · contact PI
Pittsburgh Innovation in Collaborative Training of Residents Alliance$289,329
R38 · FY2024 · HL · contact PI
Reciprocal brain-lung responses in post-stroke pneumonia$209,375
R21 · FY2024 · NS
MAVS-Mediated Pulmonary Inflammation and Injury Response During Cigarette Smoke Exposure and Influenza Viral Infection and in COPD$0
I01 · FY2024 · VA · contact PI
Reciprocal brain-lung responses in post-stroke pneumonia$251,250
R21 · FY2023 · NS
MAVS-Mediated Pulmonary Inflammation and Injury Response During Cigarette Smoke Exposure and Influenza Viral Infection and in COPD$0
I01 · FY2023 · VA · contact PI
Viral and immune-mediated CNS pathology during SARS-CoV-2 infection$1,235,421
R01 · FY2022 · AI
MAVS-Mediated Pulmonary Inflammation and Injury Response During Cigarette Smoke Exposure and Influenza Viral Infection and in COPD$0
I01 · FY2022 · VA · contact PI
MAVS-Mediated Pulmonary Inflammation and Injury Response During Cigarette Smoke Exposure and Influenza Viral Infection and in COPD$0
I01 · FY2021 · VA · contact PI
Core for COVID-19 Cohort IMPACC$940,621
U19 · FY2020 · AI
MAVS-Mediated Pulmonary Inflammation and Injury Response During Cigarette Smoke Exposure and Influenza Viral Infection and in COPD$0
I01 · FY2020 · VA · contact PI
Host-Pneumococcal Interaction in the Lung$415,774
R01 · FY2019 · HL · contact PI
Host-Pneumococcal Interaction in the Lung$415,774
R01 · FY2018 · HL · contact PI
Host-Pneumococcal Interaction in the Lung$415,774
R01 · FY2017 · HL · contact PI
Host-Pneumococcal Interaction in the Lung$12,078
R01 · FY2017 · HL · contact PI
Host-Pneumococcal Interaction in the Lung$419,553
R01 · FY2016 · HL · contact PI
Host-Pneumococcal Interaction in the Lung$423,680
R01 · FY2015 · HL · contact PI
Molecular and Cellular Interactions Between Cigarette Smoke Exposure and RSV$133,920
K08 · FY2014 · HL · contact PI
Molecular and Cellular Interactions Between Cigarette Smoke Exposure and RSV$133,920
K08 · FY2013 · HL · contact PI
Molecular and Cellular Interactions Between Cigarette Smoke Exposure and RSV$133,920
K08 · FY2012 · HL · contact PI
Molecular and Cellular Interactions Between Cigarette Smoke Exposure and RSV$133,920
K08 · FY2011 · HL · contact PI
Molecular and Cellular Interactions Between Cigarette Smoke Exposure and RSV$133,920
K08 · FY2010 · HL · contact PI